Optimizing drug development: Strategies to assess drug metabolism/transporter interaction potential - Toward a consensus

Clinical Pharmacology and Therapeutics

Volumn 70, Issue 2, 2001, Pages 103-114

  Tucker, Geoffrey T ^a,b,c   Houston, J Brian ^a,b,c   Huang, Shiew Mei ^a,b,c,d  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c Food and Drug Administration   (United Kingdom)

^d CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUFURALOL; CHLORZOXAZONE; COUMARIN; CYTOCHROME P450; DEXTROMETHORPHAN; DICLOFENAC; DRUG; ETHOXYRESORUFIN; MEPHENYTOIN; MIDAZOLAM; OMEPRAZOLE; PACLITAXEL; PHENACETIN; TESTOSTERONE; WARFARIN;

CONFERENCE PAPER; DRUG INDUSTRY; DRUG METABOLISM; DRUG RECEPTOR BINDING; DRUG RESEARCH; DRUG TRANSPORT; ENZYME INDUCTION; IN VITRO STUDY; ORGANIZATION; PRIORITY JOURNAL;

ANIMALS; BIOLOGICAL TRANSPORT; BIOTRANSFORMATION; CYTOCHROMES; DRUG AND NARCOTIC CONTROL; DRUG DESIGN; DRUG INTERACTIONS; ENZYME ACTIVATION; ENZYME ACTIVATORS; ENZYME INDUCTION; ENZYME INHIBITORS; HUMANS; METABOLIC CLEARANCE RATE; PHARMACOKINETICS;

EID: 0034883375     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1067/mcp.2001.116891     Document Type: Conference Paper

References (0)